Search results
FDA panel rejects MDMA-assisted therapies for PTSD despite high hopes from veterans
Fox News via Yahoo News· 2 days agoAn FDA panel rejected MDMA-based treatments for PTSD often used with veterans. One advocate shared...
The FDA Should Reject MDMA Therapy—but Not for the Reasons You Think
Slate· 1 day agoThe FDA will officially vote Aug. 11 on whether to approve the treatment. The agency isn’t required...
Why FDA Panel Rejected MDMA Therapy—And What’s Next For Psychedelic Medicine
Forbes· 1 day agoHigh hopes that psychedelic medicines were finally on the pathway to regulation were dashed last...
With MDMA debate spreading beyond biotech, Lykos CEO tries to dispel efficacy, safety concerns
FierceBiotech· 1 day agoA week after an FDA committee declined to support an midomafetamine (MDMA) treatment for...
MDMA’s Future As A Treatment For PTSD Is In Question
Inverse· 3 days agoWhile the FDA will still vote separately on MDMA, it generally follows the recommendation of its advisors, so its unlikely the novel treatment will gain approval. The drug ...
MDMA-maker failed its FDA hearing — and its PTSD patients
The Eagle-Tribune· 6 days agoThis week, the Food and Drug Administration’s expert advisers sent a strong message that Lykos...
FDA advisers vote against first MDMA therapy to treat PTSD
News Channel Nebraska· 5 days agoBy Deidre McPhillips, CNN
Trouble for ecstasy? What MDMA’s FDA setback could mean for psychedelics
NPR· 1 day agoGeneral Hospital, who presented on behalf of Lykos about the need for more PTSD treatment. Gorman acknowledges the Lykos' therapy protocol is more “open-ended ...
MDMA, Juul and a cardiovascular disease study. 3 health stories you may have missed — and why they...
Yahoo Life Style via AOL· 6 days agoThe panel said there wasn't enough evidence that the treatment is effective and said the risks were...
Psychedelics Stocks Are Falling After a Shocking Vote at the FDA. Here's What You Need to Know.
Motley Fool via Yahoo Finance· 4 days agoThe second question was whether the intervention is worth the risk to patients; the vote was 10-1....